Follow us on:

Linkedin Facebook

Avingtrans Plc Adaptix appoints Willem Baralt as new Chairman

Avingtrans plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Avingtrans PLC (LON:AVG) has announced that further to the statement made on 14 December 2022, Adaptix, the Oxford based emerging MedTech Company, has appointed Willem Baralt as its new Chairman. Willem, previously of Quanta Dialysis Technologies, will succeed Steve McQuillan (CEO of Avingtrans), who was appointed to the Board of Adaptix in December 2022 in an interim capacity. Steve will continue as a Non-Executive Director of Adaptix.

In 2021, Avingtrans plc invested £4m in Adaptix, for an 11.9% stake in the business and in December 2022 announced a further investment of £2m by means of a Convertible Loan Note.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    Avingtrans plc

    Avingtrans’ Adaptix named “the most exciting emerging technology”

    Avingtrans plc's Adaptix, an innovator in 3D X-Ray imaging, wins Aerospace Technology Innovation Award for its breakthrough in non-destructive testing.

    Avingtrans CEO Steve McQuillan on Record Growth, Investments and Future Strategies (VIDEO)

    Avingtrans plc CEO Steve McQuillan discusses preliminary results for the year ended 31 May 2024, highlighting record sales, strategic acquisitions, and future growth.
    Avingtrans

    Avingtrans reports Record Revenue and Strategic Growth in FY24 financial results

    Avingtrans PLC (LON:AVG) announces a remarkable 17.3% revenue increase to £136.6m for the year ended 31 May 2024, highlighting strategic investments and robust growth across energy and medical sectors.
    Avingtrans

    Avingtrans reports Record Revenue and exceeds market expectations for FY24

    Avingtrans PLC (LON:AVG) reports record revenue and adjusted EBITDA ahead of expectations for the financial year ending 31 May 2024, with strong growth across its divisions.

    Avingtrans Plc CEO Steve McQuillan on Strategic Growth, Interim Results and Outlook (VIDEO)

    Avingtrans plc CEO Steve McQuillan discusses interim results, acquisitions, and company restructuring in an exclusive interview with DirectorsTalk.
    Avingtrans plc

    Avingtrans announces 30.4% revenue growth in interim results

    Avingtrans PLC (LON:AVG) announces interim results for Nov 2023, showing a 30.4% revenue increase and 14.1% rise in adjusted EBITDA. Operating highlights include acquisitions and new contracts in various sectors.

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.